Table 2.
Typical inclusion criteria in AAV gene therapy trials, current and proposed
*Earlier trial included subjects who were HCV RNA viral load-positive, but they are now excluded because of potential need for course of steroids.
†Some trials may include HIV-positive persons who are stable with adequate CD4 counts on highly active antiretroviral therapy.
